Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Prostate. 2011 Dec 27;72(11):1214–1222. doi: 10.1002/pros.22472

Table 1.

Histopathology of prostatic epithelial cells in wild-type and Ercc1−/− tissue recombinants. The table depicts the most severe histopathological phenotype for each Ercc1−/− and wild-type tissue recombinant at 8, 16 and 24 weeks post-renal grafting. Only Ercc1−/− tissue recombinants displayed adenocarcinoma.

Ercc1 (n) Normal Hyperplasia PIN Atypical glands with features of adenocarcinoma
8 week +/+ 11 2 (18%) 5 (46%) 4 (35%) 0 (0%)
−/− 18 1 (5%) 3 (17%) 13 (72%) 1 (6%)*
16 week +/+ 15 1 (6%) 4 (27%) 10 (67%) 0 (0%)
−/− 16 0 (0%) 0 (0%) 14 (87.5%) 2 (12.5%)#
24 week +/+ 13 4 (31%) 3 (23%) 6 (46%) 0 (0%)
−/− 17 0 (0%) 0 (0%) 14 (82%) 3 (18%)+

Statistical significance between Ercc1−/− and wild-type tissue recombinants were *p = 0.020, #p = 0.0065, and +p = 0.0003 at the 8,16, and 24 week time points respectively. With serial grafting ERCC1−/− tissue recombinants progressed to a more severe histopathological phenotype more rapidly than wild-type (p=0.011).

HHS Vulnerability Disclosure